High-resolution metabolomic profiling of Alzheimer's disease in plasma.
Megan M NiedzwieckiDouglas I WalkerJennifer Christina HowellKelly D WattsDean P JonesGary W MillerWilliam T HuPublished in: Annals of clinical and translational neurology (2019)
In plasma, AD was reproducibly associated with elevated levels of glutamine and a halogen-containing compound and reduced levels of piperine. These findings provide further evidence that exposures and behavior may modify AD risks.